Literature DB >> 25504528

Identification of a novel mutation in MAGT1 and progressive multifocal leucoencephalopathy in a 58-year-old man with XMEN disease.

Fatima Dhalla1, Sarah Murray, Ross Sadler, Benjamin Chaigne-Delalande, Tomohiko Sadaoka, Elizabeth Soilleux, Gulbu Uzel, Joanne Miller, Graham Peter Collins, Christian Simon Ross Hatton, Malini Bhole, Berne Ferry, Helen M Chapel, Jeffrey I Cohen, Smita Y Patel.   

Abstract

XMEN disease (X-linked immunodeficiency with Magnesium defect, Epstein-Barr virus infection and Neoplasia) is a novel primary immune deficiency caused by mutations in MAGT1 and characterised by chronic infection with Epstein-Barr virus (EBV), EBV-driven lymphoma, CD4 T-cell lymphopenia, and dysgammaglobulinemia [1]. Functional studies have demonstrated roles for magnesium as a second messenger in T-cell receptor signalling [1], and for NKG2D expression and consequently NK- and CD8 T-cell cytotoxicity [2]. 7 patients have been described in the literature; the oldest died at 45 years and was diagnosed posthumously [1-3]. We present the case of a 58-year-old Caucasian gentleman with a novel mutation in MAGT1 with the aim of adding to the phenotype of this newly described disease by detailing his clinical course over more than 20 years.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25504528      PMCID: PMC6328310          DOI: 10.1007/s10875-014-0116-2

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  14 in total

1.  The bone marrow, B cells, and JC virus.

Authors:  Sidney A Houff; Joseph R Berger
Journal:  J Neurovirol       Date:  2008-10-16       Impact factor: 2.643

2.  Idiopathic CD4+ T lymphocytopenia presenting as progressive multifocal leukoencephalopathy: case report.

Authors:  P U Chikezie; A L Greenberg
Journal:  Clin Infect Dis       Date:  1997-03       Impact factor: 9.079

3.  Involvement of JC virus-infected mononuclear cells from the bone marrow and spleen in the pathogenesis of progressive multifocal leukoencephalopathy.

Authors:  S A Houff; E O Major; D A Katz; C V Kufta; J L Sever; S Pittaluga; J R Roberts; J Gitt; N Saini; W Lux
Journal:  N Engl J Med       Date:  1988-02-04       Impact factor: 91.245

Review 4.  XMEN disease: a new primary immunodeficiency affecting Mg2+ regulation of immunity against Epstein-Barr virus.

Authors:  Feng-Yen Li; Benjamin Chaigne-Delalande; Helen Su; Gulbu Uzel; Helen Matthews; Michael J Lenardo
Journal:  Blood       Date:  2014-02-18       Impact factor: 22.113

Review 5.  Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain.

Authors:  Michael W Ferenczy; Leslie J Marshall; Christian D S Nelson; Walter J Atwood; Avindra Nath; Kamel Khalili; Eugene O Major
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

6.  Establishment of a healthy human range for the whole blood 'OX40' assay for the detection of antigen-specific CD4+ T cells by flow cytometry.

Authors:  Ross Sadler; Elizabeth Al Bateman; Victoria Heath; Smita Y Patel; Phillip P Schwingshackl; Alice C Cullinane; Lisa Ayers; Berne L Ferry
Journal:  Cytometry B Clin Cytom       Date:  2014-02-11       Impact factor: 3.058

Review 7.  Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) Project.

Authors:  Kenneth R Carson; Daniele Focosi; Eugene O Major; Mario Petrini; Elizabeth A Richey; Dennis P West; Charles L Bennett
Journal:  Lancet Oncol       Date:  2009-08       Impact factor: 41.316

8.  Progressive multifocal leucoencephalopathy, sclerosing cholangitis, bronchiectasis and disseminated warts in a patient with primary combined immune deficiency.

Authors:  S A Misbah; G P Spickett; A Zeman; M M Esiri; T B Wallington; J B Kurtz; H M Chapel
Journal:  J Clin Pathol       Date:  1992-07       Impact factor: 3.411

Review 9.  Progressive multifocal leukoencephalopathy and idiopathic CD4 lymphocytopenia.

Authors:  Manuel Delgado-Alvarado; María José Sedano; Vicente González-Quintanilla; Enrique Marco de Lucas; José Miguel Polo; José Berciano
Journal:  J Neurol Sci       Date:  2013-03-05       Impact factor: 3.181

10.  Second messenger role for Mg2+ revealed by human T-cell immunodeficiency.

Authors:  Feng-Yen Li; Benjamin Chaigne-Delalande; Chrysi Kanellopoulou; Jeremiah C Davis; Helen F Matthews; Daniel C Douek; Jeffrey I Cohen; Gulbu Uzel; Helen C Su; Michael J Lenardo
Journal:  Nature       Date:  2011-07-27       Impact factor: 49.962

View more
  19 in total

1.  Progressive Multifocal Leukoencephalopathy in Primary Immunodeficiencies.

Authors:  Jérôme Hadjadj; Aurélien Guffroy; Christophe Delavaud; Guillaume Taieb; Isabelle Meyts; Anne Fresard; Nathalie Streichenberger; Anne-Sophie L'Honneur; Flore Rozenberg; Maud D'Aveni; Claire Aguilar; Jérémie Rosain; Capucine Picard; Nizar Mahlaoui; Marc Lecuit; Olivier Hermine; Olivier Lortholary; Felipe Suarez
Journal:  J Clin Immunol       Date:  2018-12-14       Impact factor: 8.317

Review 2.  N-linked glycosylation and homeostasis of the endoplasmic reticulum.

Authors:  Natalia Cherepanova; Shiteshu Shrimal; Reid Gilmore
Journal:  Curr Opin Cell Biol       Date:  2016-04-14       Impact factor: 8.382

3.  Interstitial lung disease in patients with common variable immunodeficiency disorders: several different pathologies?

Authors:  S Patel; C Anzilotti; M Lucas; N Moore; H Chapel
Journal:  Clin Exp Immunol       Date:  2019-07-10       Impact factor: 4.330

4.  Defective glycosylation and multisystem abnormalities characterize the primary immunodeficiency XMEN disease.

Authors:  Juan C Ravell; Mami Matsuda-Lennikov; Samuel D Chauvin; Juan Zou; Matthew Biancalana; Sally J Deeb; Susan Price; Helen C Su; Giulia Notarangelo; Ping Jiang; Aaron Morawski; Chrysi Kanellopoulou; Kyle Binder; Ratnadeep Mukherjee; James T Anibal; Brian Sellers; Lixin Zheng; Tingyan He; Alex B George; Stefania Pittaluga; Astin Powers; David E Kleiner; Devika Kapuria; Marc Ghany; Sally Hunsberger; Jeffrey I Cohen; Gulbu Uzel; Jenna Bergerson; Lynne Wolfe; Camilo Toro; William Gahl; Les R Folio; Helen Matthews; Pam Angelus; Ivan K Chinn; Jordan S Orange; Claudia M Trujillo-Vargas; Jose Luis Franco; Julio Orrego-Arango; Sebastian Gutiérrez-Hincapié; Niraj Chandrakant Patel; Kimiyo Raymond; Turkan Patiroglu; Ekrem Unal; Musa Karakukcu; Alexandre Gr Day; Pankaj Mehta; Evan Masutani; Suk S De Ravin; Harry L Malech; Grégoire Altan-Bonnet; V Koneti Rao; Matthias Mann; Michael J Lenardo
Journal:  J Clin Invest       Date:  2020-01-02       Impact factor: 14.808

5.  Diversity of XMEN Disease: Description of 2 Novel Variants and Analysis of the Lymphocyte Phenotype.

Authors:  Elizabeth M Klinken; Paul E Gray; Bethany Pillay; Lisa Worley; Emily S J Edwards; Kathryn Payne; Bruce Bennetts; Dorothy Hung; Ben A Wood; Jonathan J Chan; Glenn M Marshall; Richard Mitchell; Gulbu Uzel; Cindy S Ma; Stuart G Tangye; Andrew McLean-Tooke
Journal:  J Clin Immunol       Date:  2019-12-21       Impact factor: 8.317

Review 6.  Immunological aspects of congenital disorders of glycosylation (CDG): a review.

Authors:  Maria Monticelli; Tiago Ferro; Jaak Jaeken; Vanessa Dos Reis Ferreira; Paula A Videira
Journal:  J Inherit Metab Dis       Date:  2016-07-08       Impact factor: 4.750

Review 7.  Epstein-Barr Virus-Specific Immune Control by Innate Lymphocytes.

Authors:  Christian Münz
Journal:  Front Immunol       Date:  2017-11-24       Impact factor: 7.561

Review 8.  Human immunity against EBV-lessons from the clinic.

Authors:  Stuart G Tangye; Umaimainthan Palendira; Emily S J Edwards
Journal:  J Exp Med       Date:  2017-01-20       Impact factor: 14.307

Review 9.  Natural Killer Cell Responses during Human γ-Herpesvirus Infections.

Authors:  Christian Münz
Journal:  Vaccines (Basel)       Date:  2021-06-15

Review 10.  Impaired Control of Epstein-Barr Virus Infection in B-Cell Expansion with NF-κB and T-Cell Anergy Disease.

Authors:  Swadhinya Arjunaraja; Pamela Angelus; Helen C Su; Andrew L Snow
Journal:  Front Immunol       Date:  2018-02-08       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.